Source: International Congress 2015 – Practising personalised medicine: why, when, and how?



Rating:

Share or cite this content

Citations should be made in the following way:
Marc Humbert (Paris, France). Pulmonary hypertension: what can we learn from studies?. International Congress 2015 – Practising personalised medicine: why, when, and how?

Member's Comments

No comment yet.

Related content which might interest you: Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how? Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases Year: 2020 Clinical trials in pulmonary arterial hypertension: what they tell us Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Pulmonary hypertension in the elderly: a different disease? Source: Breathe 2016; 12: 43-49 Year: 2016 Pulmonary arterial hypertension patients underrepresented in clinical trials – Are they different? Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Pathophysiology of pulmonary hypertension: what the interested clinician needs to know Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Pulmonary hypertension: where are we in 2007? Source: ERS Live 2007 Year: 2007 Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005 Pulmonary hypertension: what does the pathology tell us? Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician Year: 2010 Presentation by an expert: Pulmonary hypertension: a taste of autoimmunity? Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 What do we learn from novel genes in pulmonary hypertension? Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life Year: 2020 Interventional treatment of pulmonary hypertension: where are we now? Source: Virtual Congress 2020 – Breathing disorders and cardiovascular diseases Year: 2020 Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018 Pulmonary embolism in young adults, what particularities? Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Pulmonary embolism and pulmonary hypertension - is our follow up adequate? Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005 Pulmonary hypertension and chronic lung disease: where are we headed? Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019 Year: 2019 Chronic thromboembolic pulmonary hypertension: do we need a new definition? Source: Eur Respir J 2014; 44: 1401-1403 Year: 2014 Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer? Source: Eur Respir J 2009; 33: 1247-1249 Year: 2009